The cases with MMR gene variants comprised almost a quarter of the identified carriers, with other prominent genes identified in the established CRC genes group (MLH3 and POLE) and the candidate CRC genes group (NOS1, SH2B3, LAMA2 and MSH3) requiring further validation studies at both the gene and variant level. Here, LAMA2 is linked to colorectal carcinoma.